N-acetylcysteine for therapy-resistant tobacco use disorder: a pilot study.

INTRODUCTION N-Acetylcysteine (NAC) may have efficacy in treating tobacco use disorder (TUD) by reducing craving and smoking reward. This study examines whether treatment with NAC may have a clinical efficacy in the treatment of TUD. METHODS A 12-week double blind randomized controlled trial was conducted to compare the clinical efficacy of NAC 3 g/day… CONTINUE READING